Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nutraceuticals in Type 2 Diabetes and Dyslipidemia
NCT03676309Phase 2Completed
- Sponsor
- Villa dei Gerani
- Start
- Sep 2017
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Villa dei Gerani. Primary endpoints: Total Cholesterol at 12 weeks and Low Density Lipoprotein Cholesterol at 12 weeks. Started Sep 2017; status: completed.
Beyond the preview
Go deeper on NCT03676309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03676309.